Live Science on MSN
New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds
By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...
Bristol Myers Squibb has won FDA approval for an injectable version of its blockbuster cancer immunotherapy Opdivo, a regulatory decision that gives patients a more convenient dosing option and ...
Please provide your email address to receive an email when new articles are posted on . Pyronaridine, a common malaria drug, has been used for more than 50 years. The agent could be repurposed to ...
Chennai, Jan. 26 -- Highlights: ...
Dec 16 (Reuters) - The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's (JNJ.N), opens new tab drug Rybrevant for a type of lung cancer, the ...
Nanobiotix (NASDAQ:NBTX) traded higher on Thursday after the French biotech announced initial results from a Phase 1 trial for JNJ-1900 (NBTXR3), a cancer injection developed by the company in ...
For people taking GLP-1 drugs, such as the mega-popular weight-loss drug Ozempic (semaglutide) — intended for type 2 diabetes patients and people with obesity — there has been some concern about the ...
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results